RVNL, Texmaco Rail shares in focus after JV signed to focus on five key areas
Texmaco, part of the Adventz Group, will hold a 49% stake, while Navratna PSU RVNL will be the majority shareholder.
Uncategorized
Lithium shares plunge in Australia as miners swing to losses
The lithium sector has been hit by writedowns and cost controls due to a supply glut and headwinds to electric-vehicle demand. Prices have plunged 86% from a record high in late 2022 and continued to drop in the first half…
India’s stock market lags emerging peers at worst pace in three decades
After years of consistently outperforming emerging market equities, India’s edge appears to be fading.
Reliance Industries AGM: Key expectations from the Street
Beyond business updates, shareholders of Reliance Industries Ltd. (RIL) will also be watching for any potential value-unlocking announcements.
50% Tariffs On India: The stocks and sectors that could take a hit
Textiles, sea food, gems and jewellery, are among the worst hit sectors as they have a significant exposure to the US market.
Sensex Today | Stock Market Live Updates: GIFT Nifty indicates further pressure at the start of monthly expiry
Stock Market Live Updates: Indian equities resume trading on Thursday after the mid-week holiday on the occasion of Ganesh Chaturthi and trading resumes on the monthly expiry day of the Nifty 50 contracts. For the Nifty, Tuesday’s low of 24,689…
S&P 500, Nasdaq futures fall after Nvidia results even as indices gain for second day
Thursday’s session will not only see the market react to Nvidia’s results, but multiple data points get reported before market open, including the Q2 GDP data, initial jobless claims and an address from Fed Governor Christopher Waller.
Nvidia Q2 Results: Stock falls in extended trade despite earnings beat; Here’s why
Nvidia’s revenue grew in excess of 50% for the ninth straight quarter, dating back to mid-2023, when the AI and data centre-led boom led to even triple-digit growth figures for the Jensen Huang-led chip manufacturer. This quarter’s growth figure, is…
Cipla completes 20% stake acquisition in Bengaluru’s iCaltech Innovations
The Indian drugmaker had announced on July 21 that it would invest about ₹5 crore through optionally convertible preference shares and one equity share to secure the stake. The deal, now closed, gives Cipla 20% voting rights in the privately…
Biocon unit gets US FDA tentative nod for diabetes drug Sitagliptin
Shares of Biocon ended 0.4% lower at ₹358.60 on Tuesday, valuing the company at about ₹47,943.52 crore.